How can the Global Fund finance innovation to improve health product supply chains in resource-limited settings?
Access to medicines and quality health products to ensure healthy populations is a global issue. It is also a strategic issue (in financial terms through maintaining the industrial fabric, creating jobs, driving the race for innovation, and enhancing the attractiveness of producer countries) as well as a key political one (governments have a duty to provide accessible care to their citizens to ensure social stability).
The Global Fund has agreed to accept in-kind payment in lieu of cash for $27.4 million in recoveries owed by Ghana. The in-kind payment consists of reforms that Ghana must implement in order for the country deliver its Supply Chain Master Plan. This is the first time that the Fund has agreed to such an arrangement.
According to the Office of the Inspector General (OIG), in-country supply chain mechanisms are neither adequate nor effective in ensuring that the right products are delivered in the correct quantities and condition, at the right place and time, and for the best value cost.
The Global Fund’s new market-shaping strategy is designed to allow the Fund to play a more active role in shaping market dynamics to increase access to health products. The new strategy, which was adopted by the Board at its meeting on 16-17 November, includes a section on preparing for when countries transition away from Fund support.
Reports on audits of grants in Rwanda and Ecuador were released by the Office of the Inspector General (OIG) at the end of December.